THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA
Deferiprone (L1) was originally designed, synthesised and screened in vitro and in vivo in 1981 by Kontoghiorghes G J following his discovery of the novel alpha-ketohydroxypyridine class of iron chelators (1978-1981), which were intended for clinical use. The journey through the years for the treatm...
Saved in:
| Main Authors: | George J Kontoghiorghes, Marios Kleanthous, Christina N. Kontoghiorghe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2020-01-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Online Access: | http://mjhid.org/index.php/mjhid/article/view/4097 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transfusion-related acute lung injury (TRALI) in two thalassaemia patients caused by the same multiparous blood donor
by: George J Kontoghiorghes
Published: (2017-10-01) -
Iron Chelators in Treatment of Iron Overload
by: Sarina Entezari, et al.
Published: (2022-01-01) -
Effect of the combination of deferiprone with ethanolic extract of Phaleria macrocarpa L. fruit in overcoming iron excess in the liver of hemosiderosis model rats
by: Rahma, et al.
Published: (2024-12-01) -
Screening for Iron Overload: Lessons from the HEmochromatosis and IRon Overload Screening (HEIRS) Study
by: Paul C Adams, et al.
Published: (2009-01-01) -
Development of Nanocomposite Microspheres for Nasal Administration of Deferiprone in Neurodegenerative Disorders
by: Radka Boyuklieva, et al.
Published: (2024-11-01)